Equity · Healthcare
TECH
Bio-Techne Corporation · NasdaqGS
The line runs $47.35 on 21 May through $72.30 on 7 August, on a scale from $40 to $80. Days the market did not trade hold the previous close, flat.
The chart above plots the price of TECH over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 54 sessions over that window: $47.35 on 21 May 2026 through $72.30 on 7 August 2026.
Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Aug 19, 2026
TECH insider trades
Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.
Showing the 12 most recent of 20 compensation filings in this window. The figures above count all of them.
TECH reported financials
TECH reported revenue of $1.2B for the fiscal year ended 30 Jun 2025. Net income over the same period was $73.4M.
Source: SEC EDGAR XBRL company facts · latest period ended 31 Mar 2026
TECH earnings
no date announced in SEC filings yet
Reported figures & scheduled dates · SEC EDGAR filings
TECH institutional holders
14 of the 45 institutional funds we track reported a TECH position for the quarter ended 30 Jun 2026 — a combined $471.2M; the latest of those filings landed 14 Aug 2026.
Showing the 10 largest of 14 reported positions. The figures above count all of them.
Source: SEC EDGAR 13F filings
TECH fails-to-deliver
On 22 Jul 2026, 98 shares of TECH failed to deliver (about $7K).
Source: SEC fails-to-deliver (CNS) data
Congressional trades in TECH
The most recent congressional trade disclosed in TECH is a purchase by April McClain Delaney (house, MD), dated 05 Dec 2025.
Source: U.S. House of Representatives financial disclosures